Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients.
Kernan NA, Klein E, Mauguen A, Torok-Castanza J, Prockop SE, Scaradavou A, Curran K, Spitzer B, Cancio M, Ruggiero J, Allen J, Harris A, Oved J, O'Reilly RJ, Boelens JJ. Kernan NA, et al. Among authors: cancio m. Transplant Cell Ther. 2024 Apr 20:S2666-6367(24)00351-8. doi: 10.1016/j.jtct.2024.04.012. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38643958
Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.
Fraint E, Farooki S, Klein E, Mauguen A, Prockop SE, Scaradavou A, Curran K, Cancio M, Spitzer B, Boelens JJ, Oved J, Harris A, O'Reilly RJ, Kernan NA. Fraint E, et al. Among authors: cancio m. Transplant Cell Ther. 2023 Jan;29(1):46.e1-46.e6. doi: 10.1016/j.jtct.2022.09.027. Epub 2022 Oct 6. Transplant Cell Ther. 2023. PMID: 36210027 Free PMC article.
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.
Curran KJ, Margossian SP, Kernan NA, Silverman LB, Williams DA, Shukla N, Kobos R, Forlenza CJ, Steinherz P, Prockop S, Boulad F, Spitzer B, Cancio MI, Boelens JJ, Kung AL, Khakoo Y, Szenes V, Park JH, Sauter CS, Heller G, Wang X, Senechal B, O'Reilly RJ, Riviere I, Sadelain M, Brentjens RJ. Curran KJ, et al. Among authors: cancio mi. Blood. 2019 Dec 26;134(26):2361-2368. doi: 10.1182/blood.2019001641. Blood. 2019. PMID: 31650176 Free PMC article. Clinical Trial.
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant.
Fabrizio VA, Kernan NA, Boulad F, Cancio M, Allen J, Higman M, Margossian SP, Mauguen A, Prockop S, Scaradavou A, Shah N, Spitzer B, Stieglitz E, Yeager N, O'Reilly RJ, Brentjens RJ, Jan Boelens J, Curran KJ. Fabrizio VA, et al. Among authors: cancio m. Bone Marrow Transplant. 2020 Nov;55(11):2160-2169. doi: 10.1038/s41409-020-0926-1. Epub 2020 May 10. Bone Marrow Transplant. 2020. PMID: 32390002 Free PMC article.
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation.
de Koning C, Prockop S, van Roessel I, Kernan N, Klein E, Langenhorst J, Szanto C, Belderbos M, Bierings M, Boulad F, Bresters D, Cancio M, Curran K, Kollen W, O'Reilly R, Scaradavou A, Spitzer B, Versluijs B, Huitema A, Lindemans C, Nierkens S, Boelens JJ. de Koning C, et al. Among authors: cancio m. Blood. 2021 Feb 11;137(6):848-855. doi: 10.1182/blood.2020007905. Blood. 2021. PMID: 33150379 Free PMC article.
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation.
Lakkaraja M, Scordo M, Mauguen A, Cho C, Devlin S, Ruiz JD, Klein E, Avecilla ST, Boulad F, Cancio MI, Curran KJ, Jakubowski AA, Kernan NA, Kung AL, O'Reilly RJ, Papadopoulos EB, Prockop S, van Roessel I, Scaradavou A, Shaffer BC, Shah G, Spitzer B, Tamari R, Giralt SA, Perales MA, Boelens JJ. Lakkaraja M, et al. Among authors: cancio mi. Blood Adv. 2022 Feb 8;6(3):1054-1063. doi: 10.1182/bloodadvances.2021005584. Blood Adv. 2022. PMID: 34788361 Free PMC article.
Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients.
Camacho-Bydume C, Mauguen A, Rodriguez-Sanchez MI, Klein E, Kernan NA, Prockop S, Boelens JJ, Papanicolaou GA, Cancio M. Camacho-Bydume C, et al. Among authors: cancio m. Cytotherapy. 2022 Apr;24(4):428-436. doi: 10.1016/j.jcyt.2021.10.002. Epub 2022 Jan 15. Cytotherapy. 2022. PMID: 35042670 Free PMC article.
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations.
Kunvarjee B, Bidgoli A, Madan RP, Vidal E, McAvoy D, Hosszu KK, Scaradavou A, Spitzer BG, Curran KJ, Cancio M, Harris AC, O'Reilly RJ, Kung AL, Prockop S, Boelens JJ, Oved JH. Kunvarjee B, et al. Among authors: cancio m. J Allergy Clin Immunol. 2023 Sep;152(3):815-817. doi: 10.1016/j.jaci.2023.05.016. Epub 2023 Jun 26. J Allergy Clin Immunol. 2023. PMID: 37367708 No abstract available.
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.
Tamari R, Scordo M, Kunvarjee BM, Proli A, Lin A, Flynn J, Cho C, Devlin S, Klein E, Boulad F, Cancio MI, Curran KJ, Jakubowski AA, Kernan NA, Kung AL, O'Reilly RJ, Papadopoulos EB, Prockop S, Scaradavou A, Shaffer BC, Shah G, Spitzer B, Gyurkocza B, Giralt SA, Perales MA, Boelens JJ. Tamari R, et al. Among authors: cancio mi. Blood Adv. 2023 Sep 26;7(18):5225-5233. doi: 10.1182/bloodadvances.2023009708. Blood Adv. 2023. PMID: 37379285 Free PMC article.
82 results